Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ai Zhu
OpenAlex ID:
A5122020796
Sequential anlotinib and camrelizumab combination therapy achieves exceptional survival in multi-driver mutated, TMB-low/PD-L1-low/MSS pulmonary sarcomatoid carcinoma: case report and literature review
2026
·
Jun Zhu
, Ai Zhu
, et al.
·
Frontiers in Immunology
Show more works
View as search
Works count:
1
Citation count:
H-index:
I10-index:
Year
Topic
Type
